Insider Trading History of Kellerman Donald J

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Kellerman Donald J since 2011. This trader's CIK number is 1145911. At the time of last reporting, Kellerman Donald J was the VP, Clinical Dev & Med Affairs of Zosano Pharma Corp. (stock ticker symbol ZSAN). Also see all insider trading activities at Zosano Pharma Corp.

Note that in the past KELLERMAN DONALD J also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Map Pharmaceuticals, Inc. (MAPP) by Kellerman Donald J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2013 MAPP 0 $0 1,429 $35,339 5,000 $0
2012 MAPP 0 $0 0 $0 2,250 $0
2011 MAPP 0 $0 0 $0 11,250 $0

Yearly summary of insider trading at Zosano Pharma Corp (ZSAN) by Kellerman Donald J

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2022 ZSAN 0 $0 4,006 $841 0 $0
2021 ZSAN 0 $0 1,709 $1,375 0 $0
2016 ZSAN 15,920 $21,014 0 $0 0 $0


Insider trading activities at 2 companies by Kellerman Donald J:

1. Map Pharmaceuticals, Inc. (MAPP)

2. Zosano Pharma Corp (ZSAN)

Table 1. Insider trading of Map Pharmaceuticals, Inc. (MAPP) by Kellerman Donald J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2013-02-01 MAPP Sale 1,429 24.73 35,339
2013-01-26 MAPP Option Ex 2,250 .00 0
2013-01-25 MAPP Option Ex 2,750 .00 0
2012-01-26 MAPP Option Ex 2,250 .00 0
2011-08-04 MAPP Option Ex 11,250 .00 0

Table 2. Insider trading of Zosano Pharma Corp (ZSAN) by Kellerman Donald J

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2022-03-31 ZSAN Sale 4,006 .21 841
2021-06-04 ZSAN Sale 1,709 .81 1,375
2016-08-19 ZSAN Buy 15,920 1.32 21,014

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Kellerman Donald J (VP, Clinical Dev & Med Affairs of Zosano Pharma Corp at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.